A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic islets

Journal of Proteomics

Volumn 96, Issue , 2014, Pages 314-327

  Sileno, Sara ^a   D'Oria, Valentina ^a   Stucchi, Riccardo ^b   Massimo, Alessio ^c   Petrini, Stefania ^a   Bonetto, Valentina ^b   Maechler, Pierre ^d   Bertuzzi, Federico ^e   Grasso, Valeria ^a   Paolella, Katia ^b   Barbetti, Fabrizio ^a,f   Massa, Ornella ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Calcium concentration; Human islet; INS 1E; Insulin secretion; Transglutaminase 2; Cell

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; CALCIUM; GLUCOSE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HISTONE H3; INSULIN; MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN; PEPTIDE; PEPTIDE A25; PROHIBITIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ACYLATION; AMIDATION; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CALCIUM HOMEOSTASIS; CELL FRACTIONATION; CELL LABELING; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; INSULIN RELEASE; INSULINOMA; MITOCHONDRION; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS;

RATTUS;

CALCIUM CONCENTRATION; FIRST PHASE INSULIN SECRETION; FPIS; HUMAN ISLET; INS-1E; INSULIN SECRETION; TG2; TRANSGLUTAMINASE 2; TRANSGLUTAMINASE 2.; Β-CELL;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CELL NUCLEUS; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; RATS; SWEETENING AGENTS; TRANSCRIPTION, GENETIC; TRANSGLUTAMINASES;

EID: 84890317322     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.11.011     Document Type: Article

References (67)

1. Lorand L., Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003, 34:140-156.
2. Fesus L., Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002, 27:534-539.
3. Griffin M., Casadio R., Bergamini C.M. Transglutaminases: nature's biological glues. Biochem J 2002, 368:377-396.
4. Park D., Choi S.S., Ha K.S. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids 2010, 39:619-631.
5. Kuo T.F., Tatsukawa H., Soichi Kojima S. New insights into the functions and localization of nuclear transglutaminase 2. FEBS J 2011, 278:4756-4767.
6. Lesort M., Attanavanich K., Zhang J., Johnson G.V. Distinct nuclear localization and activity of tissue transglutaminase. J Biol Chem 1998, 273:11991-11994.
7. Verderio E., Nicholas B., Gross S., Griffin M. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res 1998, 239:119-138.
8. Korner G., Schneider D.E., Purdon M.A., Bjornsson T.D. Bovine aortic endothelial cell transglutaminase enzyme characterization and regulation of activity. Biochem J 1989, 262:633-641.
9. Peng X., Zhang Y., Zhang H., Graner S., Williams J.F., Levitt M.L., et al. Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3. FEBS Lett 1999, 446:35-39.
10. Mann A.P., Verma A., Sethi G., Manavathi B., Wang H., Fok J.Y., et al. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor kB in cancer cells: delineation of a novel pathway. Cancer Res 2006, 66:8788-8795.
11. Dardik R., Inbal A. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res 2006, 312:2973-2982.
12. Singh U.S., Li Q., Cerione R. Identification of the eukaryotic initiation factor 5A as a retinoic acid-stimulated cellular binding partner for tissue transglutaminase II. J Biol Chem 1998, 273:1946-1950.
13. Rodolfo C., Mormone E., Matarrese P., Ciccosanti F., Farrace M.G., Garofano E., et al. Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 2004, 279:54783-54792.
14. Battaglia G., Ferrace M.G., Mastroberardino P.G., Viti I., Fimia G.M., Beeumen J.V., et al. Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders. J Neurochem 2007, 100:36-49.
15. Mastroberardino P.G., Farrace M.G., Viti I., Pavone F., Fimia G.M., Melino G., et al. "Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes. Biochim Biophys Acta 2006, 1757:1357-1365.
16. Kim S.Y., Marekov L., Bubber P., Browne S.E., Stavrovskaya I., Lee J., et al. Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem Res 2005, 30:1245-1255.
17. Oliverio S., Amendola A., Di Sano F., Farrace M.G., Fesus L., Nemes Z., et al. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol Cell Biol 1997, 17:6040-6048.
18. Mishra S., Melino G., Murphy L.J. Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein. J Biol Chem 2007, 282:18108-18115.
19. Mishra S., Murphy L.J. The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun 2006, 339:726-730.
20. Ballestar E., Abad C., Franco L. Core histones are glutaminyl substrates for tissue transglutaminase. J Biol Chem 1996, 271:18817-18824.
21. Ballestar E., Boix-Chornet M., Franco L. Conformational changes in the nucleosome followed by the selective accessibility of histone glutamines in the transglutaminase reaction: effects of ionic strength. Biochemistry 2001, 40:1922-1929.
22. Kim J.H., Choy H.E., Nam K.H., Park S.C. Transglutaminase mediated crosslinking of specific core histone subunits and cellular senescence. Ann N Y Acad Sci 2001, 928:65-70.
23. Filiano A.J., Bailey C.D., Tucholski J., Gundemir S., Johnson G.V. Transglutaminase 2 protects against ischemic insult, interacts with HIF1b, and attenuates HIF1 signaling. FASEB J 2008, 22:2662-2675.
24. Han J.A., Park S.C. Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol Cells 2000, 10:612-618.
25. Russo L., Marsella C., Nardo G., Massignan T., Alessio M., Piermarini E., et al. Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E. Acta Diabetol 2013, 50:61-72.
26. Ricordi C., Lacy P.E., Finke E.H., Olack B.J., Scharp D.W. Automated method for isolation of human pancreatic islets. Diabetes 1988, 37:413-420.
27. Vargas F., Vives-Pi M., Somoza N., Alcalde L., Armengol P., Martì M., et al. Advantages of using a cell separator and metrizamide gradients for human islet purification. Transplantation 1996, 61:1562-1566.
28. Merglen A., Theander S., Rubi B., Chaffard G., Wollheim C.B., Maechler P. Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 2004, 145:667-678.
29. De Monte L., Sanvito F., Olivieri S., Viganò F., Doglioni C., Frasson M., et al. Serological immunoreactivity against colon cancer proteome varies upon disease progression. J Proteome Res 2008, 7:504-514.
30. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Caremolla B., et al. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25:1327.
31. Pappin D.J., Hojrup P., Bleasby A.J. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 1993, 3:327-332.
32. Casoni F., Basso M., Massignan T., Gianazza E., Cheroni C., Salmona M., et al. Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J Biol Chem 2005, 280:16295-16304.
33. Cavener D.R. Sleeping Beauty, awake! Regulation of insulin gene expression by methylation of histone H3. Diabetes 2009, 58:28-29.
34. Greenberg C.S., Birckbichler P.J., Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991, 5:3071-3077.
35. Akimov S.S., Krylov D., Fleischman L.F., Belkin A.M. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000, 148:825-838.
36. Wang Z., Telci D., Griffin M. Importance of syndecan-4 and syndecan-2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res 2011, 317:367-381.
37. Nakaoka H., Perez D.M., Baek K.J., Das T., Husain A., Misono K., et al. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 1994, 264:1593-1596.
38. Chen S., Lin F., Iismaa S., Lee K.N., Birckbichler P.J., Graham R.M. Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J Biol Chem 1996, 271:32385-32391.
39. Hasegawa G., Suwa M., Ichikawa Y., Ohtsuka T., Kumagai S., Kikuchi M., et al. A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J 2003, 373(Pt 3):793-803.
40. Mishra S., Murphy L.J. Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem 2004, 279:23863-23868.
41. Brender J.R., Salamekh S., Ramamoorthy A. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc Chem Res 2012, 45:454-462.
42. Henquin J.C., Nenquin M., Stiernet P., Ahren B. In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in beta-cells. Diabetes 2006, 55:441-451.
43. Sarma A., Yang W. Calcium regulation of nucleocytoplasmic transport. Protein Cell 2011, 2:291-302.
44. Bootman M.D., Fearnley C., Smyrnias I., MacDonald F., Roderick H.L. An update on nuclear calcium signalling. J Cell Sci 2009, 122:2337-2350.
45. Calì T., Ottolini D., Brini M. Mitochondrial Ca(2+) and neurodegeneration. Cell Calcium 2012, 52:73-85.
46. 2+ homeostasis: mechanism, role, and tissue specificities. Pflugers Arch 2012, 464:3-17.
47. Suckale J., Solimena M. The insulin secretory granule as a signaling hub. Trends Endocrinol Metab 2010, 21:599-609.
48. Rizzuto R., De Stefani D., Raffaello A., Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 2012, 13:566-578.
49. Huang P.R., Hung S.C., Wang T.C. Telomeric DNA-binding activities of heterogeneous nuclear ribonucleoprotein A3 in vitro and in vivo. Biochim Biophys Acta 1803, 2010:1164-1174.
50. Ma Y.L., Peng J.Y., Zhang P., Huang L., Liu W.J., Shen T.Y., et al. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology. J Proteome Res 2009, 8:4525-4535.
51. Porzio O., Massa O., Cunsolo V., Colombo C., Malaponti M., Bertuzzi F., et al. Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Hum Mutat 2007, 28:1150-1158.
52. Chen C., Ito K., Takahashi A., Wang G., Suzuki T., Nakazawa T., et al. Distinct expression patterns of the subunits of the CCR4-NOT deadenylase complex during neural development. Biochem Biophys Res Commun 2011, 411:360-364.
53. Montes de Oca R., Shoemaker C.J., Gucek M., Cole R.N., Wilson K.L. Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners. PLoS One 2009, 4:e7050. 10.1371/journal.pone.0007050.
54. Toleman C., Paterson A.J., Whisenhunt T.R., Kudlow J.E. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J Biol Chem 2004, 279:53665-53673.
55. Copeland R.J., Bullen J.W., Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab 2008, 295:E17-E28.
56. Liu K., Paterson A.J., Konrad R.J., Parlow A.F., Jimi S., Roh M., et al. Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion. Mol Cell Endocrinol 2002, 194:135-146.
57. Mishra S., Saleh A., Espino P.S., Davie J.R., Murphy L.J. Phosphorylation of histones by tissue transglutaminase. J Biol Chem 2006, 281:5532-5538.
58. Deering T.G., Ogihara T., Trace A.P., Maier B., Mirmira R.G. Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes. Diabetes 2009, 58:185-193.
59. Allfrey V.G., Faulkner R., Mirsky E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci U S A 1964, 51:786-794.
60. Dunn K.L., Davie J.R. Stimulation of the Ras-MAPK pathway leads to independent phosphorylation of histone H3 on serine 10 and 28. Oncogene 2005, 24:3492-3502.
61. Nowak S.J., Corces V.G. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 2004, 20:214-220.
62. Crosio C., Heitz E., Allis C.D., Borrelli E., Sassone-Corsi P. Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. J Cell Sci 2003, 116:4905-4914.
63. Zhang S., Roche K., Nasheuer H.P., Lowndes N.F. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem 2011, 286:37483-37495.
64. Sakabe K., Wang Z., Hart G.W. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci U S A 2010, 107:19915-19920.
65. Montes de Oca R., Andreassen P.R., Wilson K.L. Barrier-to-autointegration factor influences specific histone modifications. Nucleus 2011, 2:580-590.
66. Bernassola F., Federici M., Corazzari M., Terrinoni A., Hribal M.L., De Laurenzi V., et al. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J 2002, 16:1371-1378.
67. Iismaa S.E., Aplin M., Holman S., Yiu T.W., Jackson K., Burchfield J.G., et al. Glucose homeostasis in mice is transglutaminase 2 independent. PLoS One 2013, 8:e63346. 10.1371/journal.pone.0063346.